InVitro Capital

InVitro Capital

Venture Capital
Small (Likely less than 50 employees, based on typical VC firm size and focus)

Overview

InVitro Capital is a venture capital firm that invests in early-stage life science companies. They focus on therapeutics, diagnostics, and research tools, often specializing in companies utilizing innovative technologies and addressing unmet medical needs. They provide not only capital but also strategic guidance and operational support to help their portfolio companies grow and succeed.

About Us

InVitro Capital's team is comprised of experienced investors, scientists, and entrepreneurs with a deep understanding of the life science industry. They leverage their network and expertise to identify promising investment opportunities and support their portfolio companies through the challenges of drug development and commercialization. They are committed to building long-term relationships with their portfolio companies and helping them achieve their full potential.

Vision

To be a leading venture capital firm in the life science industry, known for its expertise, network, and commitment to supporting the next generation of healthcare innovators.

Mission

To identify and invest in innovative life science companies that are developing groundbreaking technologies to improve human health.

Culture

InVitro Capital fosters a collaborative and supportive culture that values innovation, integrity, and a commitment to making a positive impact on society. They encourage open communication, teamwork, and a passion for the life sciences.

Headquarters

Irvine, California

Specialties & Industries

Venture CapitalLife SciencesTherapeuticsDiagnosticsResearch ToolsBiotechnologyHealthcare InvestingSeed StageEarly StageDrug DevelopmentHealthcareBiotechnologyInvestment ManagementLife SciencesStartupPrivate Company